华芢生物科技（青岛）股份有限公司（下称“公司”）3月3日发布截至2026年2月28日的月报。报告期内，公司注册股本仍为人民币117,657,522元，包含83,022,145股H股与34,635,377股非上市股份，两类股份数目较上月底均无增减变动。
公司于2026年2月未进行任何新增发行、股份购回、注销或库藏股操作。此外，公司亦未在报告期内实施新的股份期权或员工激励计划。据公告披露，H股所需的公众持股量要求已予维持，股本总数保持稳定。
公司确认已遵循香港联交所《上市规则》及相关法律规定。公告由联席公司秘书张丽婷签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.